Event Recordings
Session VIII - Strategic Vision in Drug Discovery
Atomic Resolution of Disease: New Frontiers in Drug Discovery
Jay Bradner, MD
Executive Vice President, R&D, Amgen
Leveraging AI & Digital to transform Clinical Development
Michelle Longmire, MD
Co-Founder and CEO, Medable
Session IX - Leadership Perspectives in Drug Discovery
Biotechnology’s Next Frontier
Robert Bradway, MBA
Chairman and CEO, Amgen
Our Wins Save Lives
Alexander Hardy, MBA
President and CEO, BioMarin
Discovering and Developing Transformative Medicines
Levi Garraway, MD, PhD
Executive Vice President, Head of Product Development, and CMO, Genentech
Session IX Panel Discussion
Moderator: Carolyn Bertozzi, PhD
Facilitator: Sanjay Malhotra, PhD
Robert Bradway, MBA
Chairman and CEO, Amgen
Robert Blum, MBA
President and CEO, Cytokinetics
Alexander Hardy, MBA
President and CEO, BioMarin
Levi Garraway, MD, PhD
Executive Vice President, Head of Product Development, and CMO, Genentech
Session XI - Presentation of Lifetime Achievement Award Lecture
Awardee Lecture: Physiology of GLP-1
Jens Juul Holst, MD, DMSc
Professor, Department of Biomedical Sciences and the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Awardee Lecture: GLP-1: Discovery and Health Benefits
Joel Habener, MD
Professor of Medicine, Harvard Medical School
Awardee Lecture: Unlocking GLP-1 Potential: Innovative Druggability Solutions
Lotte Bjerre Knudsen, DMSc
Chief Scientific Advisor and Head of IDEA, Novo Nordisk